Harm Reduction Group Future Growth
Future criteria checks 5/6
Harm Reduction Group is forecast to grow earnings and revenue by 121.6% and 26.6% per annum respectively.
Key information
121.6%
Earnings growth rate
n/a
EPS growth rate
| Tobacco earnings growth | 38.0% |
| Revenue growth rate | 26.6% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 01 Dec 2023 |
Recent future growth updates
Recent updates
Harm Reduction Group AB (publ) (NGM:NOHARM) Might Not Be As Mispriced As It Looks After Plunging 25%
Apr 24
Market Cool On Harm Reduction Group AB (publ)'s (NGM:NOHARM) Revenues Pushing Shares 30% Lower
Mar 05Health Check: How Prudently Does Harm Reduction Group (NGM:NOHARM) Use Debt?
Feb 29Further Upside For Harm Reduction Group AB (publ) (NGM:NOHARM) Shares Could Introduce Price Risks After 32% Bounce
Jan 05It's Down 28% But Harm Reduction Group AB (NGM:NOHARM) Could Be Riskier Than It Looks
Sep 05Does Harm Reduction Group (NGM:NOHARM) Have A Healthy Balance Sheet?
Sep 01Companies Like SealWacs (NGM:SEAL) Are In A Position To Invest In Growth
Dec 28Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 407 | N/A | N/A | N/A | 1 |
| 12/31/2025 | 354 | 1 | N/A | N/A | 1 |
| 12/31/2024 | 271 | -6 | N/A | 11 | 1 |
| 12/31/2023 | 169 | -25 | 4 | 4 | N/A |
| 9/30/2023 | 174 | -21 | 47 | 9 | N/A |
| 6/30/2023 | 177 | -21 | 29 | -5 | N/A |
| 3/31/2023 | 180 | -13 | -33 | -32 | N/A |
| 12/31/2022 | 178 | -11 | -28 | -27 | N/A |
| 9/30/2022 | 154 | -11 | -83 | -44 | N/A |
| 6/30/2022 | 122 | -11 | -63 | -28 | N/A |
| 3/31/2022 | 118 | -12 | -4 | -4 | N/A |
| 12/31/2021 | 80 | -11 | -15 | -15 | N/A |
| 9/30/2021 | 29 | -8 | -9 | -9 | N/A |
| 6/30/2021 | 25 | -5 | -7 | -7 | N/A |
| 3/31/2021 | N/A | -2 | -1 | -1 | N/A |
| 12/31/2020 | N/A | -2 | -1 | -1 | N/A |
| 9/30/2020 | 28 | 0 | 3 | 3 | N/A |
| 6/30/2020 | 15 | 0 | 3 | 3 | N/A |
| 3/31/2020 | N/A | -1 | -1 | -1 | N/A |
| 12/31/2019 | N/A | -1 | -1 | -1 | N/A |
| 9/30/2019 | N/A | -2 | -2 | -2 | N/A |
| 6/30/2019 | N/A | -2 | -2 | -2 | N/A |
| 3/31/2019 | N/A | -3 | -3 | -3 | N/A |
| 12/31/2018 | N/A | -3 | -2 | -2 | N/A |
| 9/30/2018 | N/A | -2 | -2 | -2 | N/A |
| 6/30/2018 | N/A | -2 | -2 | -2 | N/A |
| 3/31/2018 | N/A | -2 | -2 | -2 | N/A |
| 12/31/2017 | N/A | -2 | -3 | -3 | N/A |
| 9/30/2017 | N/A | -3 | N/A | -2 | N/A |
| 6/30/2017 | N/A | -3 | N/A | -3 | N/A |
| 3/31/2017 | N/A | -3 | N/A | -3 | N/A |
| 12/31/2016 | N/A | -3 | N/A | -2 | N/A |
| 9/30/2016 | N/A | -2 | N/A | -2 | N/A |
| 6/30/2016 | N/A | -2 | N/A | -2 | N/A |
| 3/31/2016 | N/A | -2 | N/A | -2 | N/A |
| 12/31/2015 | N/A | -2 | N/A | -1 | N/A |
| 9/30/2015 | N/A | -1 | N/A | -1 | N/A |
| 6/30/2015 | N/A | -1 | N/A | -1 | N/A |
| 3/31/2015 | N/A | -1 | N/A | -1 | N/A |
| 12/31/2014 | N/A | 0 | N/A | 0 | N/A |
| 9/30/2014 | N/A | 0 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NOHARM is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1%).
Earnings vs Market: NOHARM is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: NOHARM is expected to become profitable in the next 3 years.
Revenue vs Market: NOHARM's revenue (26.6% per year) is forecast to grow faster than the Swedish market (1.7% per year).
High Growth Revenue: NOHARM's revenue (26.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if NOHARM's Return on Equity is forecast to be high in 3 years time